Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1971 Dec;24(9):822–826. doi: 10.1136/jcp.24.9.822

The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases

D Ogston 1, N B Bennett 1, C M Ogston 1
PMCID: PMC477192  PMID: 5139989

Abstract

Components of the blood fibrinolytic system were measured in 18 patients with hepatic cirrhosis, in two patients with acute hepatic necrosis, and in 10 patients with hepatic metastases. The frequency of an elevation of plasminogen activator and a reduction in plasminogen in hepatic cirrhosis has been confirmed. Patients with compensated cirrhosis had low levels of the serum inhibitor of plasminogen activation while those with severe hepatic insufficiency or coma due to cirrhosis or hepatic necrosis had elevated levels. The presence of hepatic metastases was associated with reduced plasminogen activator levels and an increase in the fibrinogen concentration.

Full text

PDF
822

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ALKJAERSIG N., FLETCHER A. P., SHERRY S. xi-Aminocaproic acid: an inhibitor of plasminogen activation. J Biol Chem. 1959 Apr;234(4):832–837. [PubMed] [Google Scholar]
  3. ASTRUP T., RASMUSSEN J., AMERY A., POULSEN H. E. Fibrinolytic activity of cirrhotic liver. Nature. 1960 Feb 27;185:619–620. doi: 10.1038/185619a0. [DOI] [PubMed] [Google Scholar]
  4. BARNHART M. I., RIDDLE J. M. Cellular localization of profibrinolysin (plasminogen). Blood. 1963 Mar;21:306–321. [PubMed] [Google Scholar]
  5. Bennett N. B. A method for the quantitative assay of inhibitor of plasminogen activation in human serum. Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):12–22. [PubMed] [Google Scholar]
  6. Bennett N. B., Ogston C. M., Ogston D. Studies on the blood fibrinolytic enzyme system following acute myocardial infarction. Clin Sci. 1967 Feb;32(1):27–37. [PubMed] [Google Scholar]
  7. Blombäck B., Carlson L. A., Franzén S., Zetterqvist E. Turnover of 131-I-labelled fibrinogen in man. Studies in normal subjects, in congenital coagulation factor deficiency states, in liver cirrhosis, in polycythemia vera and in epidermolysis bullosa. Acta Med Scand. 1966 May;179(5):557–574. doi: 10.1111/j.0954-6820.1966.tb07973.x. [DOI] [PubMed] [Google Scholar]
  8. Das P. C., Cash J. D. Fibrinolysis at rest and after exercise in hepatic cirrhosis. Br J Haematol. 1969 Nov;17(5):431–443. doi: 10.1111/j.1365-2141.1969.tb01391.x. [DOI] [PubMed] [Google Scholar]
  9. FLETCHER A. P., BIEDERMAN O., MOORE D., ALKJAERSIG N., SHERRY S. ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES. J Clin Invest. 1964 Apr;43:681–695. doi: 10.1172/JCI104953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. GROSSI C. E., MORENO A. H., ROUSSELOT L. M. Studies on spontaneous fibrinolytic activity in patients with cirrhosis of the liver and its inhibition by epsilon amino caproic acid. Ann Surg. 1961 Mar;153:383–393. doi: 10.1097/00000658-196103000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GROSSI C. E., ROUSSELOT L. M., PANKE W. F. Coagulation defects in patients with cirrhosis of the liver undergoing portasystemic shunts. Am J Surg. 1962 Oct;104:512–526. doi: 10.1016/0002-9610(62)90387-2. [DOI] [PubMed] [Google Scholar]
  12. HILDER F. M., GUNZ F. W. THE EFFECT OF AGE ON NORMAL VALUES OF THE WESTERGEN SEDIMENTATION RATE. J Clin Pathol. 1964 May;17:292–293. doi: 10.1136/jcp.17.3.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. JOHANSSON S. A. STUDIES ON BLOOD COAGULATION FACTORS IN A CASE OF LIVER CIRRHOSIS. REMISSION OF THE HEMORRHAGIC TENDENCY ON TREATMENT WITH HEPARIN. Acta Med Scand. 1964 Feb;175:177–183. doi: 10.1111/j.0954-6820.1964.tb00564.x. [DOI] [PubMed] [Google Scholar]
  14. KWAAN H. C., LO R., MCFADZEAN A. J. Antifibrinolytic activity in primary carcinoma of the liver. Clin Sci. 1959 May;18:251–261. [PubMed] [Google Scholar]
  15. KWAAN H. C., MCFADZEAN A. J., COOK J. Plasma fibrinolytic activity in cirrhosis of the liver. Lancet. 1956 Jan 21;270(6908):132–136. doi: 10.1016/s0140-6736(56)91093-5. [DOI] [PubMed] [Google Scholar]
  16. MATTII R., AMBRUS J. L., SOKAL J. E., MINK I. PRODUCTION OF MEMBERS OF THE BLOOD COAGULATION AND FIBRINOLYSIN SYSTEMS BY THE ISOLATED PERFUSED LIVER. Proc Soc Exp Biol Med. 1964 May;116:69–72. doi: 10.3181/00379727-116-29161. [DOI] [PubMed] [Google Scholar]
  17. Merskey C., Johnson A. J., Kleiner G. J., Wohl H. The defibrination syndrome: clinical features and laboratory diagnosis. Br J Haematol. 1967 Jul;13(4):528–549. doi: 10.1111/j.1365-2141.1967.tb00762.x. [DOI] [PubMed] [Google Scholar]
  18. O'CONNELL R. A., GROSSI C. E., ROUSSELOT L. M. ROLE OF INHIBITORS OF FIBRINOLYSIS IN HEPATIC CIRRHOSIS. Lancet. 1964 Nov 7;2(7367):990–991. doi: 10.1016/s0140-6736(64)90933-x. [DOI] [PubMed] [Google Scholar]
  19. Ogston C. M., Ogston D. Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Pathol. 1966 Jul;19(4):352–356. doi: 10.1136/jcp.19.4.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. PURCELL G., Jr, PHILLIPS L. L. FIBRINOLYTIC ACTIVITY IN CIRRHOSIS OF THE LIVER. Surg Gynecol Obstet. 1963 Aug;117:139–144. [PubMed] [Google Scholar]
  21. RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]
  22. Rake M. O., Flute P. T., Pannell G., Williams R. Intravascular coagulation in acute hepatic necrosis. Lancet. 1970 Mar 14;1(7646):533–537. doi: 10.1016/s0140-6736(70)90767-1. [DOI] [PubMed] [Google Scholar]
  23. SHERRY S., LINDEMEYER R. I., FLETCHER A. P., ALKJAERSIG N. Studies on enhanced fibrinolytic activity in man. J Clin Invest. 1959 May;38(5):810–822. doi: 10.1172/JCI103863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. TODD A. S. Fibrinolysis autographs. Nature. 1958 Feb 15;181(4607):495–496. doi: 10.1038/181495b0. [DOI] [PubMed] [Google Scholar]
  25. Tytgat G., Collen D., De Vreker R., Verstraete M. Investigations on the fibrinolytic system in liver cirrhosis. Acta Haematol. 1968;40(5):265–274. doi: 10.1159/000208914. [DOI] [PubMed] [Google Scholar]
  26. ZETTERQVIST E., von FRANCKEN Coagluation disturbances with manifest bleeding in extrahepatic portal hypertension and in liver cirrhosis. Preliminary results of heparin treatment. Acta Med Scand. 1963 Jun;173:753–760. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES